Tag

Mrna Vaccines

All articles tagged with #mrna vaccines

Personalized mRNA Cancer Vaccines Show Promise Amid Turbulence
health1 month ago

Personalized mRNA Cancer Vaccines Show Promise Amid Turbulence

A small Memorial Sloan Kettering study finds a patient-specific mRNA vaccine for pancreatic cancer can provoke strong immune responses and deliver long-term survivors, despite a turbulent year of funding and public skepticism around mRNA. Eight of 16 patients had a meaningful immune response and seven are alive six years after the trial; larger multisite trials and industry backing are advancing the approach, which also includes non-personalized, off-the-shelf vaccines aiming to trigger broader anti-tumor immunity.

mRNA vaccines prime CD8+ T cells through two dendritic routes and cross-dressed MHC-I
science1 month ago

mRNA vaccines prime CD8+ T cells through two dendritic routes and cross-dressed MHC-I

Nature reports that mRNA–LNP vaccines prime CD8+ T cells not through the classic cDC1 cross-presentation, but via redundant input from both cDC1 and cDC2 dendritic cells; a substantial portion of priming comes from cross-dressing—peptide–MHC-I complexes transferred from non-hematopoietic cells in a type I interferon–dependent process—broadening T-cell activation to antigens not encoded by the vaccine and supporting anti-tumor immunity and memory.

Misinformation could slow the next wave of cancer vaccines
health2 months ago

Misinformation could slow the next wave of cancer vaccines

Researchers are advancing personalized mRNA cancer vaccines that may transform cancer care, but the spread of misinformation—notably the turbo cancer myth tying COVID-19 vaccines to aggressive cancers—could erode public trust and hinder adoption; proactive, transparent science communication and clinician conversations are essential to realizing these vaccines’ potential.

Sanofi shelves mRNA seasonal flu effort, pivots to proven vaccines
business4 months ago

Sanofi shelves mRNA seasonal flu effort, pivots to proven vaccines

Sanofi has deprioritized its phase 1 mRNA seasonal flu program, scrapping the effort as part of a broader strategic shift, while continuing to pursue an mRNA vaccine for an H5 pandemic and focusing on established influenza vaccines (Fluzone High-Dose, Flublok). The influenza/COVID vaccine franchise generated €2.3 billion last year, a 6% decline from 2024 amid lower US immunization rates, and the company underscored a multi‑platform vaccine strategy, including the Dynavax acquisition, as its growth path.

Hidden COVID Vaccine Side Effect Revealed
health6 months ago

Hidden COVID Vaccine Side Effect Revealed

A study suggests that mRNA COVID vaccines like Pfizer and Moderna may enhance survival rates in cancer patients undergoing immunotherapy, potentially 'priming' the immune system to fight cancer more effectively, though more research is needed; the vaccines remain primarily important for preventing COVID-19 complications.

COVID-19 mRNA vaccines enhance cancer treatment and survival
health7 months ago

COVID-19 mRNA vaccines enhance cancer treatment and survival

New research suggests that COVID-19 mRNA vaccines may boost survival rates in patients with advanced lung and skin cancers when administered within 100 days of starting immunotherapy, potentially paving the way for a universal cancer vaccine. The findings, based on patient data and mouse experiments, are preliminary but promising, prompting plans for further clinical trials.